COVID-19: The experience from Italy.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
COVID-19
/ complications
Chilblains
/ pathology
Child
Erythema Multiforme
/ virology
Exanthema
/ virology
Female
Humans
Italy
/ epidemiology
Male
Middle Aged
Prevalence
Prognosis
Retrospective Studies
SARS-CoV-2
Skin Diseases
/ epidemiology
Skin Diseases, Vascular
/ virology
Urticaria
/ virology
Young Adult
Journal
Clinics in dermatology
ISSN: 1879-1131
Titre abrégé: Clin Dermatol
Pays: United States
ID NLM: 8406412
Informations de publication
Date de publication:
Historique:
entrez:
11
5
2021
pubmed:
12
5
2021
medline:
25
5
2021
Statut:
ppublish
Résumé
A wide range of cutaneous signs are attributed to COVID-19 infection. This retrospective study assesses the presence and impact of dermatologic manifestations related to the spread of COVID-19 in Lombardy, the geographic district with the first outbreak in Italy. A cohort of 345 patients with laboratory confirmed COVID-19 was collected from February 1, 2020 to May 31, 2020. Cutaneous signs and dermatologic diagnoses were recorded on admission, and during the course of the disease. Of the 345 patients included in the study, 52 (15%) had new-onset dermatologic conditions related to COVID-19. We observed seven major cutaneous clinical patterns, merged under 3 main groups: Exanthems, vascular lesions, and other cutaneous manifestations. Each subset was detailed with prevalence, age, duration, prognosis, and histology. Cutaneous findings can lead to suspect COVID-19 infection and identify potentially contagious cases with indolent course.
Identifiants
pubmed: 33972039
pii: S0738-081X(20)30243-1
doi: 10.1016/j.clindermatol.2020.12.008
pmc: PMC7746129
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12-22Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors have no conflicts of interest to declare.
Références
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452
pubmed: 32339344
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
J Am Acad Dermatol. 2020 Sep;83(3):e231
pubmed: 32446827
J Am Acad Dermatol. 2020 Jul;83(1):e61-e63
pubmed: 32339703
Am J Dermatopathol. 2020 Aug;42(8):564-570
pubmed: 32701690
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e346-e347
pubmed: 32330324
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e445-e447
pubmed: 32452545
Br J Dermatol. 2020 Jul;183(1):71-77
pubmed: 32348545
J Am Acad Dermatol. 2020 Aug;83(2):674-675
pubmed: 32442696
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293
pubmed: 32330334
Int J Dermatol. 2020 Aug;59(8):e268-e269
pubmed: 32572958
JAAD Case Rep. 2020 Apr 18;6(6):489-492
pubmed: 32363225
Br J Haematol. 2020 Jun;189(5):846-847
pubmed: 32304577
Clin Exp Dermatol. 2020 Dec;45(8):1065-1067
pubmed: 32421857
Acta Derm Venereol. 2020 Apr 23;100(8):adv00124
pubmed: 32315073
J Am Acad Dermatol. 2020 Aug;83(2):486-492
pubmed: 32479979
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Dermatol Ther. 2020 Nov;33(6):e13891
pubmed: 32584431
Int J Dermatol. 2020 Jun;59(6):739-743
pubmed: 32329897